Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of CD31/PECAM-1 (platelet endothelial cell adhesion molecule 1) by blastic plasmacytoid dendritic cell neoplasms.

JAMA dermatology - 1 Jan 2014

Salva Katrin A, Haemel Anna K, Pincus Laura B, Liu Jing, Sundram Uma, Guitart Joan, Longley B Jack, Wood Gary S

Abstract excerpt

IMPORTANCE: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare malignant neoplasm with cutaneous manifestations and a rapidly progressive clinical course. The diagnosis relies on characteristic clinicopathologic and immunopathologic features. However, the overlap of immunophenotypic features with other cancers, as well as newly discovered interpersonal and intrapersonal phenotypic variations, renders...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Dendritic Cells

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease Progression

Share to Immunohistochemistry

Share to Phenotype

Share to Platelet Endothelial Cell Adhesion Molecule-1

Share to Skin Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 24225899
DOI: 10.1001/jamadermatol.2013.7141
PMCID: PMC4058994

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of CD31/PECAM-1 (platelet endothelial cell adhesion molecule 1) by blastic plasmacytoid dendritic cell neoplasms.PMID 24225899Read ↗

Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients.Semantic proximity Read ↗

Neoplasms derived from plasmacytoid dendritic cells.Semantic proximity Read ↗

Blastic plasmacytoid dendritic cell neoplasmSemantic proximity Read ↗

Blastic Plasmacytoid Dendritic Cell Neoplasm: Updates in Diagnostic and Molecular Pathology.Semantic proximity Read ↗

Blastic plasmacytoid dendritic cell neoplasm: A case report and review of the literatureSemantic proximity Read ↗

Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.Semantic proximity Read ↗

Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations.Semantic proximity Read ↗

The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid Neoplasms.Semantic proximity Read ↗

Plasmacytoid dendritic cells in the setting of myeloid neoplasms: Diagnostic guide to challenging pathologic presentations.Semantic proximity Read ↗

Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.Semantic proximity Read ↗

Characterization of CD56+ dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm?Semantic proximity Read ↗

Blastic Plasmacytoid Dendritic Cell Neoplasm in Children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.